Investigator Selection
Longstanding relationships with the right investigative sites are integral to the
success of every clinical trial. With extensive experience working with thousands
of investigators around the world in multiple therapeutic specialties such as
cardiovascular,
metabolic, and
oncologic drug development, Medpace ensures investigators are selected
correctly the first time and global study enrollment proceeds quickly and efficiently.
Our comprehensive selection process requires every site's Primary Investigator
and Coordinator undergo detailed interviews with our
therapeutically-focused experts to guarantee proficiency with each study
protocol and ensure the site has the patient population and capacity to conduct
the study.
We know what it takes to make projects successful and that's why we've
developed consistent, longstanding, and positive relationships with a global network
of investigative sites. Medpace Clinical Research Associates (CRAs) provide the
best organizational representation to our sites – and, as a result, investigators
welcome a collegiate relationship and prioritize Medpace studies.
Investigator Questionnaire